INVESTORS & PARTNERSHIP
- BiPER Therapeutics’ experienced management team, pipeline of first-in-class candidate and solid development plan is expected to lead to numerous clinical and preclinical value drivers
- BiPER Therapeutics secured a Seed financing and has been backed by several non-dilutive financings
- Interested investors are encouraged to connect with us to learn more
PHARMA / BIOTECH
- BiPER Therapeutics is open to evaluate potential partnership with Pharma or Biotech that would like to extend their portfolio of therapeutics or to evaluate their products in combination with our drug candidates
- BiPER Therapeutics has extensive collaborations with leading academic centers to further advance the pipeline of drug candidates.
BiPER Therapeutics is always open to discussing new collaborations.
Feel free to contact us via our contact page